Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study

Kashiwagi, A. ; Kazuta, K. ; Goto, K. ; Yoshida, S. ; Ueyama, E. ; Utsuno, A.

Diabetes, obesity & metabolism, 2015-03, Vol.17 (3), p.304-308

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível